Bhanwra S, Ahluwalia K. Empagliflozin: the latest SGLT2 inhibitor on the block. Int J Basic Clin Pharmacol [Internet]. 2016 Dec. 28 [cited 2025 Nov. 13];5(2):539-42. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/297